Matthias Ulrich Kassack (Matthias U Kassack, M U Kassack)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 17

Top Topics

Cell Cycle Arrest

Histone Deacetylase

Estrogen Receptor

Top Venues

International journal of molecular sciences

Pharmaceuticals (Basel, Switzerland)

Purinergic signalling

Clinical epigenetics

This page only lists publications with an associated author ORCID identifier.

Publications

Katja Schiedlauske, Alina Deipenbrock, Marc Pflieger, Alexandra Hamacher, Jan Hänsel, Matthias Ulrich Kassack, Thomas Kurz, Nicole E Teusch
Novel Histone Deacetylase (HDAC) Inhibitor Induces Apoptosis and Suppresses Invasion via E-Cadherin Upregulation in Pancreatic Ductal Adenocarcinoma (PDAC). Pharmaceuticals (Basel, Switzerland) 17 (6) (2024)
Laura S Pradel, Yu-Lin Ho, Holger Gohlke, Matthias Ulrich Kassack
The Antioxidant and HDAC-Inhibitor α-Lipoic Acid Is Synergistic with Exemestane in Estrogen Receptor-Positive Breast Cancer Cells. International journal of molecular sciences 25 (15) (2024)
Laura S Pradel, Yu-Lin Ho, Holger Gohlke, Matthias Ulrich Kassack
The Antioxidant and HDAC-Inhibitor α-Lipoic Acid Is Synergistic with Exemestane in Estrogen Receptor-Positive Breast Cancer Cells. International journal of molecular sciences 25 (15) (2024)
Katja Schiedlauske, Alina Deipenbrock, Marc Pflieger, Alexandra Hamacher, Jan Hänsel, Matthias Ulrich Kassack, Thomas Kurz, Nicole E Teusch
Novel Histone Deacetylase (HDAC) Inhibitor Induces Apoptosis and Suppresses Invasion via E-Cadherin Upregulation in Pancreatic Ductal Adenocarcinoma (PDAC). Pharmaceuticals (Basel, Switzerland) 17 (6) (2024)
Christian Schrenk, Lukas M Bollmann, Corinna Haist, Arthur Bister, Constanze Wiek, Maria Wecker, Dennis Roth, Patrick Petzsch, Karl Köhrer, Alexandra Hamacher, Helmut Hanenberg, Georg Fluegen, Matthias Ulrich Kassack
Synergistic Interaction of the Class IIa HDAC Inhibitor CHDI0039 with Bortezomib in Head and Neck Cancer Cells. International journal of molecular sciences 24 (6) (2023)
Christian Schrenk, Lukas M Bollmann, Corinna Haist, Arthur Bister, Constanze Wiek, Maria Wecker, Dennis Roth, Patrick Petzsch, Karl Köhrer, Alexandra Hamacher, Helmut Hanenberg, Georg Fluegen, Matthias Ulrich Kassack
Synergistic Interaction of the Class IIa HDAC Inhibitor CHDI0039 with Bortezomib in Head and Neck Cancer Cells. International journal of molecular sciences 24 (6) (2023)
Christian Schrenk, Lukas M Bollmann, Corinna Haist, Arthur Bister, Constanze Wiek, Maria Wecker, Dennis Roth, Patrick Petzsch, Karl Köhrer, Alexandra Hamacher, Helmut Hanenberg, Georg Fluegen, Matthias Ulrich Kassack
Synergistic Interaction of the Class IIa HDAC Inhibitor CHDI0039 with Bortezomib in Head and Neck Cancer Cells. International journal of molecular sciences 24 (6) (2023)
Lukas M Bollmann, Alexander J Skerhut, Yodita Asfaha, Nadine Horstick, Helmut Hanenberg, Alexandra Hamacher, Thomas Kurz, Matthias Ulrich Kassack
The Novel Class IIa Selective Histone Deacetylase Inhibitor YAK540 Is Synergistic with Bortezomib in Leukemia Cell Lines. International journal of molecular sciences 23 (21) (2022)
Kim-Thao Le, Jan J Bandolik, Matthias Ulrich Kassack, Kenneth R Wood, Claudia Paetzold, Marc S Appelhans, Claus M Passreiter
New Acetophenones and Chromenes from the Leaves of Melicope barbigera A. Gray. Molecules (Basel, Switzerland) 26 (3) (2021)
Yu Zhang, Patrick Babczyk, Andreas Pansky, Matthias Ulrich Kassack, Edda Tobiasch
P2 Receptors Influence hMSCs Differentiation towards Endothelial Cell and Smooth Muscle Cell Lineages. International journal of molecular sciences 21 (17) (2020)
Annabelle Friedrich, Ann-Sophie Assmann, Lena Schumacher, Jana V Stuijvenberg, Matthias Ulrich Kassack, Wolfgang A Schulz, Wynand P Roos, Finn K Hansen, Marc Pflieger, Thomas Kurz, Gerhard Fritz
In Vitro Assessment of the Genotoxic Hazard of Novel Hydroxamic Acid- and Benzamide-Type Histone Deacetylase Inhibitors (HDACi). International journal of molecular sciences 21 (13) (2020)
Chenyin Wang, Alexandra Hamacher, Patrick Petzsch, Karl Köhrer, Guenter Niegisch, Michèle Janine Hoffmann, Wolfgang A Schulz, Matthias Ulrich Kassack
Combination of Decitabine and Entinostat Synergistically Inhibits Urothelial Bladder Cancer Cells via Activation of FoxO1. Cancers 12 (2) (2020)
Ana J Rodrigues Moita, Jan J Bandolik, Finn K Hansen, Thomas Kurz, Alexandra Hamacher, Matthias Ulrich Kassack
Priming with HDAC Inhibitors Sensitizes Ovarian Cancer Cells to Treatment with Cisplatin and HSP90 Inhibitors. International journal of molecular sciences 21 (21) (2020)
Nicole Brockmann, Parichat Sureechatchaiyan, David Müller, Tatiana Hennicke, Ralf Hausmann, Gerhard Fritz, Alexandra Hamacher, Matthias Ulrich Kassack
Profiling of a suramin-derived compound library at recombinant human P2Y receptors identifies NF272 as a competitive but non-selective P2Y2 receptor antagonist. Purinergic signalling 15 (3) (2019)
Aline Kaletsch, Maria Pinkerneil, Michèle Janine Hoffmann, Ananda Ayyappan Jaguva Vasudevan, Chenyin Wang, Finn K Hansen, Constanze Wiek, Helmut Hanenberg, Christoph G W Gertzen, Holger Gohlke, Matthias Ulrich Kassack, Thomas Kurz, Wolfgang A Schulz, Guenter Niegisch
Effects of novel HDAC inhibitors on urothelial carcinoma cells. Clinical epigenetics 10 (1) (2018)
Parichat Sureechatchaiyan, Alexandra Hamacher, Nicole Brockmann, Bjoern Stork, Matthias Ulrich Kassack
Adenosine enhances cisplatin sensitivity in human ovarian cancer cells. Purinergic signalling 14 (4) (2018)
I Buß, A Hamacher, N Sarin, Matthias Ulrich Kassack, Ganna V Kalayda
Relevance of copper transporter 1 and organic cation transporters 1-3 for oxaliplatin uptake and drug resistance in colorectal cancer cells. Metallomics : integrated biometal science 10 (3) (2018)